8-2-337, ROAD NO.3 BANJARA HILLS, HYDERABAD, K7
Still awaiting approval for a major near-term trigger, sources say
To release Q4 and full year FY26 results on Tuesday, May 12th, 2026; Earnings call slated @19:30 PM IST / 10:00 AM ET
Intimation of Board Meeting for Consideration of Final Dividend Under Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015
LLC Receives Final Penalty Decision from Russian Tax Authority
Disclosure Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Sale of Wholly Owned Subsidiary.
Allotment of Equity Shares on exercise of Stock Options under ESOPs
Announces Code of Practices and Procedures for Fair Disclosures of Un-published Price Sensitive Information
Announces Launch of India’s First DCGI-Approved Semaglutide Injection ‘Obeda®’ for Type 2 Diabetes
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
No filings found
Initial Statement of Beneficial Ownership
Registration Statement for Depositary Shares
Confidential Treatment Order
Submission Upload
Correspondence